2023
DOI: 10.1002/mds.29615
|View full text |Cite
|
Sign up to set email alerts
|

Band‐Specific Altered Cortical Connectivity in Early Parkinson's Disease and its Clinical Correlates

Matteo Conti,
Andrea Guerra,
Mariangela Pierantozzi
et al.

Abstract: BackgroundFunctional connectivity (FC) has shown promising results in assessing the pathophysiology and identifying early biomarkers of neurodegenerative disorders, such as Parkinson's disease (PD).ObjectivesIn this study, we aimed to assess possible resting‐state FC abnormalities in early‐stage PD patients using high‐density electroencephalography (EEG) and to detect their clinical relationship with motor and non‐motor PD symptoms.MethodsWe enrolled 26 early‐stage levodopa naïve PD patients and a group of 20 … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 12 publications
(2 citation statements)
references
References 91 publications
0
2
0
Order By: Relevance
“…disease duration; MDS-UPDRS Movement Disorder Society-Sponsored Revision of the Unified Parkinson’s Disease Rating Scale; H&Y Hoehn and Yahr scale; MoCA Montreal Cognitive Assessment; BDI-II Beck Depression Inventory II; LEDD (S1) L-DOPA equivalent daily dose in the first session (L-DOPA); LEDD (S2) L-DOPA equivalent daily dose in the second session (L-DOPA + OPC); SD standard deviation. LEDD are calculated according to previous literature data [ 37 , 38 ]. Clinical scores reflect the values recorded before the L-DOPA intake (T0) in the L-DOPA session (i.e., without Opicapone)…”
Section: Resultsmentioning
confidence: 99%
“…disease duration; MDS-UPDRS Movement Disorder Society-Sponsored Revision of the Unified Parkinson’s Disease Rating Scale; H&Y Hoehn and Yahr scale; MoCA Montreal Cognitive Assessment; BDI-II Beck Depression Inventory II; LEDD (S1) L-DOPA equivalent daily dose in the first session (L-DOPA); LEDD (S2) L-DOPA equivalent daily dose in the second session (L-DOPA + OPC); SD standard deviation. LEDD are calculated according to previous literature data [ 37 , 38 ]. Clinical scores reflect the values recorded before the L-DOPA intake (T0) in the L-DOPA session (i.e., without Opicapone)…”
Section: Resultsmentioning
confidence: 99%
“…These tools are designed to inform the development of personalized treatment strategies. The growing interest in “walking,” “balance,” and “nonmotor symptoms ( Conti et al, 2023 )” reflects a broader approach to understanding PD, emphasizing the need to address the multifaceted nature of the disease that affects both motor and cognitive functions ( Bosch et al, 2021 ; Costa et al, 2023 ; Guo et al, 2024 ). As researchers continue to investigate these topics, integrating advanced technologies and holistic approaches promises to drive innovations in the management of PD, potentially leading to earlier detection, more effective treatments, and better patient outcomes.…”
Section: Discussionmentioning
confidence: 99%